The paradox of increased natriuretic hormones in congestive heart failure patients: Does the endocrine heart also fail in heart failure?

European Heart Journal

Volumn 24, Issue 16, 2003, Pages 1471-1472

  Goetze, Jens Peter ^a   Kastrup, Jens ^a   Rehfeld, Jens F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; FURIN; HORMONE PRECURSOR; PROTEINASE;

BLOOD PRESSURE; CONGESTIVE HEART FAILURE; EDITORIAL; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE OVERLOAD; HUMAN; NATRIURESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING;

ATRIAL NATRIURETIC FACTOR; ENDOCRINE GLANDS; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN;

EID: 0041467795     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00283-5     Document Type: Editorial

References (16)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
2. de Bold AJ, Borenstein HB, Veress AT et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
3. de Bold AJ, Ma KK, Zhang Y et al. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 2001;79:705-14.
4. Cowie MR, Struthers AD, Wood DA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
5. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
6. McDonagh TA, Robb SD, Murdoch DR et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
7. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
8. Corti R, Burnett JC Jr, Rouleau JL et al. Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation 2001;104:1856-62.
9. Colucci WS, Elkayam U, Horton DP et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000;343:246-53.
10. Cheng JW. Nesiritide: review of clinical pharmacology and role in heart failure management. Heart Dis 2002;4:199-203.
11. Gabrielsen A, Bie P, Holstein-Rathlou NH et al. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2001;281:R459-67.
12. Christoffersen C, Goetze JP, Bartels ED et al. Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart. Hypertension 2002;40:54-60.
13. Wu F, Yan W, Pan J et al. Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J Biol Chem 2002;277:16900-5.
14. Dschietzig T, Richter C, Bartsch C et al. The pregnancy hormone relaxin is a player in human heart failure. FASEB J 2001;15:2187-95.
15. Goetze JP, Kastrup J, Pederson F et al. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002;48:1035-42.
16. Hunt PJ, Yandle TG, Nicholls MG et al. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995;214:1175-83.